These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21763370)

  • 1. Targeted TFO delivery to hepatic stellate cells.
    Yang N; Singh S; Mahato RI
    J Control Release; 2011 Oct; 155(2):326-30. PubMed ID: 21763370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPMA polymer-based site-specific delivery of oligonucleotides to hepatic stellate cells.
    Yang N; Ye Z; Li F; Mahato RI
    Bioconjug Chem; 2009 Feb; 20(2):213-21. PubMed ID: 19133717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor-mediated hepatic uptake of M6P-BSA-conjugated triplex-forming oligonucleotides in rats.
    Ye Z; Cheng K; Guntaka RV; Mahato RI
    Bioconjug Chem; 2006; 17(3):823-30. PubMed ID: 16704223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted delivery of a triplex-forming oligonucleotide to hepatic stellate cells.
    Ye Z; Cheng K; Guntaka RV; Mahato RI
    Biochemistry; 2005 Mar; 44(11):4466-76. PubMed ID: 15766277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodistribution and hepatic uptake of triplex-forming oligonucleotides against type alpha1(I) collagen gene promoter in normal and fibrotic rats.
    Cheng K; Ye Z; Guntaka RV; Mahato RI
    Mol Pharm; 2005; 2(3):206-17. PubMed ID: 15934781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced hepatic uptake and bioactivity of type alpha1(I) collagen gene promoter-specific triplex-forming oligonucleotides after conjugation with cholesterol.
    Cheng K; Ye Z; Guntaka RV; Mahato RI
    J Pharmacol Exp Ther; 2006 May; 317(2):797-805. PubMed ID: 16452392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albumin modified with mannose 6-phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells.
    Beljaars L; Molema G; Weert B; Bonnema H; Olinga P; Groothuis GM; Meijer DK; Poelstra K
    Hepatology; 1999 May; 29(5):1486-93. PubMed ID: 10216133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intercalator conjugates of pyrimidine locked nucleic acid-modified triplex-forming oligonucleotides: improving DNA binding properties and reaching cellular activities.
    Brunet E; Corgnali M; Perrouault L; Roig V; Asseline U; Sørensen MD; Babu BR; Wengel J; Giovannangeli C
    Nucleic Acids Res; 2005; 33(13):4223-34. PubMed ID: 16049028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA damage produced by 125I-triplex-forming oligonucleotides as a measure of their successful delivery into cell nuclei.
    Panyutin IV; Sedelnikova OA; Bonner WM; Panyutin IG; Neumann RD
    Ann N Y Acad Sci; 2005 Nov; 1058():140-50. PubMed ID: 16394133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mannose 6-phosphate-modified bovine serum albumin nanoparticles for controlled and targeted delivery of sodium ferulate for treatment of hepatic fibrosis.
    Li FQ; Su H; Chen X; Qin XJ; Liu JY; Zhu QG; Hu JH
    J Pharm Pharmacol; 2009 Sep; 61(9):1155-61. PubMed ID: 19703364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplatin-conjugated triplex-forming oligonucleotides form adducts with both strands of DNA.
    Campbell MA; Miller PS
    Bioconjug Chem; 2009 Dec; 20(12):2222-30. PubMed ID: 19950917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of a triplex-forming oligonucleotide-pyrrolobenzodiazepine conjugate.
    Zhilina ZV; Ziemba AJ; Trent JO; Reed MW; Gorn V; Zhou Q; Duan W; Hurley L; Ebbinghaus SW
    Bioconjug Chem; 2004; 15(6):1182-92. PubMed ID: 15546183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA binding and antigene activity of a daunomycin-conjugated triplex-forming oligonucleotide targeting the P2 promoter of the human c-myc gene.
    Carbone GM; McGuffie E; Napoli S; Flanagan CE; Dembech C; Negri U; Arcamone F; Capobianco ML; Catapano CV
    Nucleic Acids Res; 2004; 32(8):2396-410. PubMed ID: 15121897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and Biodistribution of GDC-0449 Loaded Micelles in Normal and Liver Fibrotic Mice.
    Dutta R; Kumar V; Peng Y; Evande RE; Grem JL; Mahato RI
    Pharm Res; 2017 Mar; 34(3):564-578. PubMed ID: 27995525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioconjugation of oligonucleotides for treating liver fibrosis.
    Ye Z; Houssein HS; Mahato RI
    Oligonucleotides; 2007; 17(4):349-404. PubMed ID: 18154454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted delivery of drugs for liver fibrosis.
    Li F; Wang JY
    Expert Opin Drug Deliv; 2009 May; 6(5):531-41. PubMed ID: 19413460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and evaluation of hepatic stellate cell selective, surface conjugated, peroxisome proliferator-activated receptor-gamma ligand loaded liposomes.
    Patel G; Kher G; Misra A
    J Drug Target; 2012 Feb; 20(2):155-65. PubMed ID: 21913877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted delivery of siRNA to hepatocytes and hepatic stellate cells by bioconjugation.
    Zhu L; Mahato RI
    Bioconjug Chem; 2010 Nov; 21(11):2119-27. PubMed ID: 20964335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An efficient antigene activity and antiproliferative effect by targeting the Bcl-2 or survivin gene with triplex forming oligonucleotides containing a W-shaped nucleoside analogue (WNA-βT).
    Taniguchi Y; Sasaki S
    Org Biomol Chem; 2012 Oct; 10(41):8336-41. PubMed ID: 22987068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of a targeting drug for antifibrosis of liver; a conjugate for delivering glycyrrhetin to hepatic stellate cells.
    Zhang J; Zhang QS; Chen XM; Tian GY
    Glycoconj J; 2002 Jul; 19(6):423-9. PubMed ID: 14707489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.